Related Experiment Video
Updated: Jul 14, 2026
The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse
Published on: May 16, 2016
Modulation of murine osteoarthritis
J Chayen1, L Bitensky, M G Chambers
1Department of Medicine, Charing Cross and Westminster Medical School, Charing Cross Hospital, London, UK.
Abstract:
Up to nine out of 10 male STR/ORT mice develop osteoarthritis (OA) of the medial tibial cartilage at an early age. This has now been shown to be related to changes in the activity and distribution of monoamine oxidase which is related to the metabolism of catecholamines. Treatment with diclofenac sodium tended to normalize this activity but there was no significant histological improvement. It was therefore postulated that two influences were involved in the development of OA: a cellular and an extracellular factor. The first was improved by diclofenac sodium; the second, namely oedema of the matrix, was improved by tribenoside. In very preliminary studies, feeding the two drugs simultaneously resulted in 7/9 mice having no sign of OA.
Insights
Osteoarthritis (OA) in male STR/ORT mice is linked to monoamine oxidase activity. Combined treatment with diclofenac sodium and tribenoside showed promising results in preventing OA development.
Area of Science:
- Biomedical research
- Orthopedics
- Pharmacology
Background:
- Male STR/ORT mice exhibit a high incidence of early-onset osteoarthritis (OA), particularly in the medial tibial cartilage.
- OA development in these mice is associated with altered monoamine oxidase (MAO) activity, impacting catecholamine metabolism.
Purpose of the Study:
- To investigate the role of MAO activity and catecholamine metabolism in OA pathogenesis.
- To evaluate the efficacy of diclofenac sodium and tribenoside, individually and in combination, in preventing OA development in STR/ORT mice.
Main Methods:
- Monitoring MAO activity and distribution in male STR/ORT mice.
- Histological assessment of tibial cartilage for OA.
- Pharmacological intervention using diclofenac sodium and tribenoside.
Main Results:
- Diclofenac sodium partially normalized MAO activity but did not yield significant histological improvement.
- Tribenoside addressed extracellular matrix edema, a proposed secondary factor in OA.
- Simultaneous administration of diclofenac sodium and tribenoside resulted in 7 out of 9 mice showing no signs of OA.
Conclusions:
- OA pathogenesis in STR/ORT mice involves both cellular and extracellular factors.
- Combined therapy targeting both factors demonstrated significant potential in preventing OA.
- Further research is warranted to explore this dual-action therapeutic approach for osteoarthritis.
More Related Videos
12:23Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
07:06Destabilization of the Medial Meniscus and Cartilage Scratch Murine Model of Accelerated Osteoarthritis
Published on: July 6, 2022